Search
for
Sort by
Research 271–300 of 1000+
- Meta-analysis identifies novel risk loci and yields systematic insights into the biology of male-pattern baldness
- Identification of Anabolic Selective Androgen Receptor Modulators with Reduced Activities in Reproductive Tissues and Sebaceous Glands
- Effects of lifelong testosterone exposure on health and disease using Mendelian randomization
- Simultaneous quantitation of nine hydroxy-androgens and their conjugates in human serum by stable isotope dilution liquid chromatography electrospray ionization tandem mass spectrometry
- Preventive and Therapeutic Efficacy of Finasteride and Dutasteride in TRAMP Mice
- In Vitro and In Vivo Regulation of SRD5A mRNA Expression of Supercritical Carbon Dioxide Extract from Asparagus racemosus Willd. Root as Anti-Sebum and Pore-Minimizing Active Ingredients
- Case-Only Trees and Random Forests for Exploring Genotype-Specific Treatment Effects in Randomized Clinical Trials with Dichotomous End Points
- Risk of Depression after 5 Alpha Reductase Inhibitor Medication: Meta-Analysis
- Connarus semidecandrus Jack Exerts Anti-Alopecia Effects by Targeting 5α-Reductase Activity and an Intrinsic Apoptotic Pathway
- Author response: Effects of lifelong testosterone exposure on health and disease using Mendelian randomization
- Synopsis: 2005 Annual Meeting of the American Society of Andrology
- Patient-reported outcomes, provider-reported outcomes, and physiologic parameters after gender-affirming hormone treatment in Canada: a systematic review
- Hydrogel crosslinking modulates macrophages, fibroblasts, and their communication, during wound healing
- Decision letter: Effects of lifelong testosterone exposure on health and disease using Mendelian randomization
- The First Visit: Consult and Workup Before Sperm Banking
- Appearance and Internal Aging
- Serenoa repens (Saw palmetto) for Lower Urinary Tract Symptoms (LUTS): The Evidence for Efficacy and Safety of Lipidosterolic Extracts. Part I
- Evaluating the safety profile of α-1 blockers, 5α-reductase inhibitors, and PDE5I for BPH: a disproportionality analysis of real-world adverse events based on FDA adverse event reporting system (FAERS)
- Referee report. For: Recent advances in treatment for Benign Prostatic Hyperplasia [version 1; referees: 2 approved]
- Guidelines on the use of finasteride in androgenetic alopecia
- The endoscopic surgical monitoring system-guided impact factors exploring of blood loss and fluid absorption during plasmakinetic TURP: a prospective study in high-risk BPH patients
- Ejaculations and Benign Prostatic Hyperplasia: An Impossible Compromise? A Comprehensive Review
- Biochemical and Histopathological evaluation of prostatic tissue under effect of Pterostilbene in benign prostatic hyperplasia rat model
- The Effect of Finasteride in Men with Benign Prostatic Hyperplasia
- Androgen Receptor Antagonists (Antiandrogens) Structure-Activity Relationships
- Hormone Blocking Anticancer Drugs
- Regulation of masculinization: androgen signalling for external genitalia development
- Fate of Prominin-1 Expressing Dermal Papilla Cells during Homeostasis, Wound Healing and Wnt Activation
- Effect of herbal mixture (RAA) on hair growth in C57BL/6 mice
- A concise review- Development of an analytical method and validation of dutasteride